MedPath

Effect of Stellate Ganglion Block on New Atrial Fibrillation After Coronary Artery Bypass Grafting

Not Applicable
Completed
Conditions
Stellate Ganglion Block
Interventions
Procedure: Stellate nerve block
Registration Number
NCT05932485
Lead Sponsor
Yangzhou University
Brief Summary

Post-operative new-onset atrial fibrillation (POAF) is one of the most common arrhythmias in adults after direct intracardiac surgery with extracorporeal circulation. The incidence of POAF in coronary artery bypass grafting (CABG) is approximately 30%. POAF can lead to an increased risk of complications such as stroke, heart failure, and acute kidney injury, which not only prolongs the patient's hospital stay, but also increases hospital costs and mortality. operation, extracorporeal circulation, and the patient's underlying conditions (such as age, gender, hypertension, and diabetes), which cause sympathetic activation, inflammatory response, and myocardial ischemia in the organism. The stellate ganglion block (SGB) regulates the sympathetic tone of the innervated nerves and thus the autonomic function of the body. SGB can effectively regulate the sympathetic-parasympathetic imbalance. Also, SGB may exert some anti-inflammatory effects. In this study, ultrasound-guided SGB was used in CABG patients to investigate its effect on the occurrence of POAF.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
124
Inclusion Criteria
  • Patients undergoing first-time and elective coronary artery bypass grafting;
  • ASA grade II-IV;
  • The preoperative ECG showed sinus heart rate.
Exclusion Criteria
  • The patient refused to participate in this study;
  • Surgical procedures include any other type of heart surgery in addition to CABG;
  • Allergic to known general anesthesia drugs;
  • Patients with a history of neck surgery or abnormal neck anatomy;
  • Patients with contraindications to SGB.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Left stellate ganglion blockStellate nerve blockLeft stellate ganglion block under ultrasound guidance was administered with 0.375% Ropivacaine hydrochloride 5 ml
Primary Outcome Measures
NameTimeMethod
The occurrence of new atrial fibrillation was detected by ECG monitoringWithin 5 days after surgery

ECG monitor shows atrial fibrillation. To be specific: 1)Irregular R-R interval (when atrioventricular conduction is present), 2) P wave disappearance, 3) irregular atrial activity.

Secondary Outcome Measures
NameTimeMethod
AF burdenwithin 5 days after surgery

The percentage of the time during which atrial fibrillation occurs in the overall recorded time.

Duration of the first episode of POAFwithin 5 days after surgery

The duration from the onset to the resolution of the first atrial fibrillation after surgery.

Need for Antiarrhythmic treatmentswithin 5 days after the operation

Record the types of medications used and whether electrical cardioversion has been used.

the concentration of interleukin-6end of surgery, 24 hour postoperatively, 72hour postoperatively, 5 day postoperatively

Interleukin-6 (IL-6) is an important cytokine that plays a key role in immune responses, inflammation, and tumor development.

the concentration of CRPend of surgery,24 hour postoperatively ,72 hour postoperatively ,5 day postoperatively

C-reactive protein (CRP) is a protein produced by the liver that is mainly used to indicate the presence of inflammation in the body.

Changes of intraoperative Left ventricular diastolic functionT1 (after sternotomy and before CPB) and T2 (30 minute after CPB cessation).

Left ventricular diastolic function were measured by transesophageal echocardiography (TEE)

the concentration of Hs-cTnTend of surgery, 24hour postoperatively, 72hour postoperatively

hs-cTnT is an important biomarker used for detecting cardiac injury.

the concentration of CK-MBend of surgery, 24hour postoperatively, 72hour postoperatively

CK-MB is an enzyme primarily found in cardiac muscle cells. Its concentration is commonly used to assess cardiac damage, especially in the case of myocardial infarction

postoperative adverse reactionsFrom date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

Record the occurrence of adverse reactions postoperative

Trial Locations

Locations (1)

the Affiliated Hospital of Yangzhou University, Yangzhou University

🇨🇳

Yangzhou, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath